BioSpace News Archive

Deals

Compugen Announces Purchase of Company Shares by its Board of Directors and Members of Management

Compugen Ltd. announced that its entire board of directors and members of management purchased Company shares on the open market during March 2019.

March 26, 2019
·
3 min read
Drug Development

Aldeyra Therapeutics Announces Positive Top-Line Results from the Phase 3 ALLEVIATE Trial in Patients with Allergic Conjunctivitis

Key secondary endpoint of clinically relevant two-point ocular itch score improvement achieved for both tested reproxalap concentrations

March 26, 2019
·
9 min read
Pharm Country

Industry Roundtable: Home-Based Care Delivers a Positive Impact on Clinical Outcomes and Patient Satisfaction

Industry thought leaders attribute growth in home-based care to convergence of consumerism, value-based care and focus on social determinants

March 26, 2019
·
6 min read
Policy

Internet2 and National Science Foundation Announce Selection of First-Phase Research Proposals for Exploring Clouds for Acceleration of Science (E-CAS) Project

NSF-funded Internet2 project will engage researchers from George Washington University, the Massachusetts Institute of Technology, Purdue University, San Diego Supercomputing Center, State University of New York, and University of Wisconsin, supported by resources from Amazon Web Services and Google Cloud

March 26, 2019
·
6 min read
Business

Schrödinger Appoints Professor Brian Shoichet to Scientific Advisory Board

Schrödinger announced the appointment of Professor of Chemistry Brian Shoichet, Ph.D., a widely published thought leader in the field of computational drug discovery, to its scientific advisory board.

March 26, 2019
·
2 min read
Drug Development

Initial Phase 2 Data From an IMV Clinical Study Continues to Demonstrate DPX-Survivac’s Prior Trend as a Potential Monotherapy Treatment for Advanced Ovarian Cancer

IMV Inc., a clinical stage immuno-oncology corporation, announced preliminary data from the phase 2 cohort of the DECIDE clinical study.

March 26, 2019
·
4 min read
Drug Development

Can-Fite Announces Phase II Advanced Liver Cancer Top-Line Results for its Orphan/Fast Track Drug Namodenoson

Conference call with management scheduled for Tuesday March 26 at 8.30 a.m. Eastern time

March 26, 2019
·
10 min read
Neptune Begins Commercial Production and Shipping of Cannabis Extracts

Neptune Wellness Solutions Inc. is pleased to announce that it has completed initial commercial production lots and is now shipping cannabis extracts from its licensed, GPP facility in Sherbrooke, Quebec.

March 26, 2019
·
5 min read
Deals

MYOS RENS Technology Announces the Date for the Release of Fourth Quarter and Fiscal Year 2018 Results, Conference Call and Webcast

MYOS RENS Technology Inc. announced that it will provide financial results for the fourth quarter and fiscal year 2018 on Wednesday, March 27, 2019 after the market closes.

March 26, 2019
·
3 min read
Genetown

Leading Experts Publish a Roadmap for Critical Areas of Research in Amyloidosis

The Amyloidosis Research Consortium announced the publication of Advancing Amyloidosis: A Research Roadmap; a consensus vision of research priorities aimed at increasing the pace and efficiencies of amyloidosis research most likely to improve the lives of patients.

March 26, 2019
·
2 min read